Activin-A is increasingly recognized as a potential therapeutic agent for conditions such as brain injury and inflammatory diseases. Studies have shown that it can help reduce damage and inflammation, ...

Inclusion bodies, once considered a hindrance in recombinant protein production, are now recognised for their potential as reservoirs of bioactive proteins and functional biomaterials. In bacterial ...

France’s Saint‑Julien site adds a bioprocess development suite for upstream/downstream scale-up of recombinant proteins, ...

Endotoxin-free proteins provide a more reliable choice for preclinical research, precise cellular experiments, and ...

KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

Support organoid research with scalable human-based systems that enhance reproducibility and accelerate breakthroughs in ...